Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

A thermostable, safe, and effective NDV GVII recombinant vaccine was generated.Fusion gene replacement with GVII did not affect GI K148/08 virus thermostability.Strain rK148/GVII-F provided adequate protection against a lethal NDV challenge.Oropharyngeal shedding was significantly reduced on post-challenge days 5 and 7.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03079457.2023.2263395DOI Listing

Publication Analysis

Top Keywords

lethal ndv
8
comparative protective
4
protective efficacy
4
efficacy newly
4
newly generated
4
generated live
4
live recombinant
4
recombinant thermostable
4
thermostable highly
4
highly attenuated
4

Similar Publications

Background: Aster tataricus, a perennial terrestrial herb with a rich history of use in traditional medicine, is renowned for its therapeutic properties. However, despite the widespread use of Aster tataricus, its antiviral efficacy and mode of action against viruses have not yet been studied. Here, we demonstrated that Aster tataricus extract (ATE) has antiviral effects and an underlying mechanism of action both in vitro and in vivo.

View Article and Find Full Text PDF

Background: Newcastle disease virus (NDV) has emerged as a tumor-lysing agent in a variety of cancers. Previous studies have shown that NDV has cytolytic activity in gliomas; however, the underlying mechanisms have not been fully elucidated.

Methods: Comparing the glioma cells LN229 controlled group with the infected group of NDV rLa Sota-GFP strain, we strive to observe the changes in the genome and protein levels as well as the activation of the signalling pathways before and after the infection at the cellular level and at the level of the genes in the transcriptome, to study the molecular mechanism of necroptosis of the NDV-infected lethal LN229.

View Article and Find Full Text PDF

Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1.

Npj Viruses

August 2024

Center for Translational Medicine, Department of Biomedical and Pharmaceutical Sciences, School of Pharmacy, University of Montana, Missoula, MT, USA.

Many different platforms have been used to develop highly protective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans. However, protection has eroded over time due to the emergence of antigenically diverse viral variants, especially the Omicron subvariants. One successful platform for the generation of SARS-CoV-2 vaccines are recombinant spike protein vaccines, of which two are licensed in the United States and Europe.

View Article and Find Full Text PDF

Research note: Antiviral effect of remdesivir against experimental Newcastle disease virus infection in chickens.

Poult Sci

June 2025

Department of Basic Sciences, College of Veterinary Medicine, University of Sulaimani, New Sulaimani, Street 27, Sulaymaniyah 46001, Kurdistan Region, Iraq. Electronic address:

Newcastle disease (ND), caused by the Newcastle disease virus (NDV), has no approved therapy, and vaccination often fails to eradicate infection in endemic areas. In this study, the antiviral effect of remdesivir was tested against experimental ND in broilers. First, the NDV was isolated and identified from an outbreak in a broiler farm in Sulaymaniyah, Iraq.

View Article and Find Full Text PDF